Toxoplasmosis and Metabolic Disorders among Children with Autism

Authors

  • K. T. Fityan Department of Biology, College of Science, University of Baghdad, Al-Jadriya Campus, Baghdad, Iraq
  • H. S. Al-Warid Department of Biology, College of Science, University of Baghdad, Al-Jadriya Campus, Baghdad, Iraq

DOI:

https://doi.org/10.4314/njpar.v45i2.19

Keywords:

Autism, children, Toxoplasmosis, Iraq

Abstract

It has recently come to light that toxoplasmosis may be linked to a number of neurological and developmental conditions, including autism, and the current study aimed to screen for anti-Toxoplasma antibodies in children with autism and metabolic changes that may be related to toxoplasmosis. The study was conducted from November 2023 to February 2024 in Baghdad, Iraq. A total of 88 children
between the ages of 2-11 years participated in this study. A psychopathologist diagnosed 44 of them with autism, while the remaining 44 were regarded as the control group because they did not exhibit any autistic symptoms. Each child had serum samples drawn and analysed for the following: lipid profile, anthropometric measurements, anti-Toxoplasma antibodies, adiponectin, leptin, chemerine, and Adipocyte Fatty Acid-Binding Protein (AFABP). Metabolic syndrome was assessed in each participant. Of the patients with autism, 31.82% showed anti-Toxoplasma antibodies compared to only 11.36% in the control group. A significant correlation (p<0.01) was found between the seropositivity rates of T. gondii and autism. Four subgroups were established based on previous findings: Autism-Toxoplasma-positive, Autism-Toxoplasma-negative, control Toxoplasma-positive, and control-Toxoplasma-negative. There was no
statistically significant difference in body mass index (BMI) between the control group and the autistic patients, whereas the control group with Toxoplasma +ve had the highest BMI value when compared to the other groups. Cholesterol levels were significantly lower than the control, while no significant differences were observed in cholesterol levels among the four subgroups. No significant
differences were observed in HDL levels among the four subgroups. The results also revealed that leptin was the only adipokine that was significantly increased in patients with autism. In contrast, adiponectine, chemerine, and AFABP levels did not significantly vary among the subgroups. Finally, metabolic syndrome was significantly associated with autism (P< 0.05). 

         Views | Download: 14 / 0

References

Liu, Q., Singla, L. D., & Zhou, H. (2012). Vaccines against Toxoplasma gondii: status, challenges and future directions. Human Vaccines & Immunotherapeutics, 8:1305–8. doi: 10.4161/hv.21006

Hill, D., & Dubey, J. P. (2002) Toxoplasma gondii: transmission, diagnosis and prevention. Clinical Microbiology and Infection, 8(10):634-40. DOI: 10.1046/j.1469-0691.2002.00485.x

Gaulin, C., Ramsay, D., Thivierge, K., Tataryn, J., Courville, A., Martin, C., Cunningham, P., Désilets, J., Morin, D., Dion, R. A. (2020). Toxoplasmosis among Canadian Deer Hunters Associated with Consumption of Undercooked Deer Meat Hunted in the United States. Emerging Infectious Diseases, 26(2):199-205. doi: 10.3201/eid2602.191218

Weiss, L. M. & Kim, K. (2007). Toxoplasma gondii: the model apicomplexan: perspectives and methods. Illustrated editionsAcademic Press; 367–86.

Lai, M. C., Lombardo, M. V., Baron-Cohen, S. (2014) Autism. Lancet, 383(9920):896-910. doi: 10.1016/S0140-6736(13)61539-1

Nayeri, T., Sharif, M., Sarvi, S., Moosazadeh, M., Montazeri, M., Aghayan, S. A., Balalami, M. J., Gholami, S., Hosseininejad, Z., Saberi, R., Anvari, D., Gohardehi, S., Daryani, A. (2019) Is there any association between Toxoplasma gondii infection and depression? a systematic review and meta-analysis. PLoS One, 10:1371. doi: 10.1371/journal.pone.0218524

Fond, G., Capdevielle, D., Macgregor, A., Attal, J., Larue, A., Brittner, M., Ducasse,. D, Boulenger, J. P. Toxoplasma gondii (2013).Apotential role in the genesis of psychiatric disorders. L'Encéphale, 39(1):38–43. doi: 10.1016/j.encep.2012.06.014

SAS. (2018). Statistical Analysis System, User's Guide. Statistical. Version 9.6th ed SAS Institute. Inc. Cary. N.C. USA.

Spann, M. N., Sourander, A., Surcel, H. M., Hinkka-Yli-Salomäki, S., Brown, A. S. (2017). Prenatal 447 Nigerian Journal of Parasitology

toxoplasmosis antibody and childhood autism. Autism Research, 10(5):769–777. doi: 10.1002/aur. 722.

El-Sayed, S. H., Al-Shewy, K. A. H., Abdin, E. M., Hasan, H. M. (2024). Seroprevalence of toxoplasmosis among children with autism. Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 60:42. doi.org/10.1186/s41983-024-00816-w

Prandota, J., Noha,A., Khadiga,A., Zaki, O. (2015). Increased seroprevalence of chronic toxoplasmosis in autistic children: special reference to the patho-physiology of IFN-gamma and NO overproduction. International Journal of Neurology Research, 1(3):102–22.DOI: 10.13140/RG.2.1.1077.1687

Erman E., Demir, E. Y., Cetinkol, Y., Calgin, M. K., Erdil, A., Erturk, E. Y., Dagli, A. (2017).The seroprevalence of antibodies to Toxoplasma gondii among children with autism, Dusunen Adam; 30: 309–315. DOI: 10.5350/DAJPN2017300404

Gouda, M. A. & Shafey, D. (2020). Detection of Anti Toxoplasma antibodies in children with autism in Shebin Al-Kom district Menoufia Governorate, Egypt. Egyptian Journal of Medical Microbiology, 29(1): 167-172. Doi: 10.21608/ejmm.2020.249875

Kamal Nor, N., Ghozali, A. H., Ismail, J. (2019). Prevalence of overweight and obesity among children and adolescents with autism spectrum disorder and associated risk factors. Frontiers in pediatrics, 7:38. doi: 10.3389/fped.2019.00038

Rouphael, M., Sacre, Y., Bitar, T., Andres, C. R., Hleihel, W. (2024). Body Composition and Anthropometric Measurements in Children andAdolescents withAutism Spectrum Disorder:ACase-Control Study in Lebanon. Nutrients, 16(6): 847. doi: 10.3390/nu16060847.

Bandini, L., Curtin, C., Phillips, S., Anderson, S. E., Maslin, M. (2017). Must, A. Changes in food selectivity in children with autism spectrum disorder. Autism and Developmental Disorders, 47(2): 439–446. DOI: 10.1007/s10803-016-2963-6

Bandini, L. G., Gleason, J., Curtin, C., Lividini, K.,Anderson, S. E., Cermak, S.A., Maslin, M., Must,A. (2013) Comparison of physical activity between children with autism spectrum disorders and typically developing children. Autism, 17: 44–54. doi: 10.1177/1362361312437416.

Park, S. Y., Cervesi, C., Galling, B., Molteni, S., Walyzada, F., Ameis, S. H., Gerhard, T., Olfson, M., Correll, C. U. (2016) Antipsychotic use trends in youth with autism spectrum disorder and/or intellectual disability: A meta-analysis. American Academy of Child & Adolescent Psychiatry, 55(6): 456–468. doi: 10.1016/j.jaac.2016.03.012

Bachmann-Gagescu, R., Mefford, H. C., Cowan, C., Glew, G. M., Hing, A. V., Wallace, S., Bader, P. I., Hamati, A., Reitnauer, P. J., Smith, R., Stokon, D. W., Muhle, H., Helbig, I., Eichler, E. E., Ballif, B. C., Rodenfeld, J., Tsuchiya, K. D. (2010). Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity. Genetics in Medicine, 12(10):641–647. doi:10.1001/2013.jamapsychiatry.71

Reeves, S., Perrier, L., Goldman, J., Freeth, D., Zwarenstein, M. (2013). Interprofessional education: effects on professional practice and healthcare outcomes (update). Cochrane Database of Systematic Reviews, 3: CD002213. doi: 10.1002/14651858.CD002213.pub3.

Al-Halbousi, Y. R., Al-Warid, H. S. (2024). Lipid Profile Parameters and Adipokines among Adolescents Infected with Toxoplasmosis. Iraqi Journal of Science, 65(5):2410-2417. DOI: https://doi.org/10.24996/ijs.2024.65.5.5

Alvarado-Esquivel, C., Loera-Moncivais, N., Hernandez-Tinoco, J., Sanchez-Anguiano, L. F., Hernandez-Madrid, G., Rabago-Sanchez, E., Centeno-Tinoco, M. M., Sandoval-Carrillo, A. A., SalasPacheco, J. M., Campos-Moreno, O. V., Antuna-Salcido, E. I. (2017). Lack of Association Between Toxoplasma gondii Infection and Diabetes Mellitus:AMatched Case-Control Study in a Mexican Population.Clinical Medicine & Research, 9(6) :508-511. doi: 10.14740/jocmr3029w

Ranieri, A., Mennitti, C., Falcone, N., La Monica, I., Di Iorio, M. R., Tripodi, L., Gentile, A., Vitale, M., Pero, R., Pastore, L., D Argenio, V., Scudiero, O., Lombardo, B. (2023). Positive effects of physical activity in autism spectrum disorder: How influences behaviour, metabolic disorder and gut microbiota. Front Psychiatry, 14:1238797. doi: 10.3389/fpsyt.2023.1238797

Coppens, I., Sinai, A. P., Joiner, K. A. (2000). Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition. Cell Biology, 149: 167–180. DOI: 10.1083/jcb.149.1.167

Dhanasekara, C. S., Ancona, D., Cortes, L., Hu, A., Rimu, A. H., Robohm-Leavitt, C., Payne, D., Wakefield, S. M., Mastergeorge, A. M., Kahathuduwa, C. N. (2023). Association Between Autism Spectrum Disorders and Cardiometabolic Diseases: A Systematic Review and Meta-analysis. JAMA Fityan and Al-Warid: Toxoplasmosis and Metabolic Disorders among Children with Autism 448 Pediatrics, 177(3) : 248-257. DOI: 10.1001/jamapediatrics.2022.5629

Charron, A. J., Sibley, L. D.(2002). Host cells: mobilizable lipid resources for the intracellular parasite Toxoplasma gondii. Cell Science, 115(15):3049-59. DOI: 10.1242/jcs.115.15.3049

Coppens, P., Hungerford, S., Yamaguchi, S., Yamadori, A.(2002) Crossed aphasia: an analysis of the symptoms, their frequency, and a comparison with left-hemisphere aphasia symptomatology. Brain and Language, 83(3): 425-63. doi: 10.1016/s0093-934x(02)00510-2.

Sagud, M., Mihaljevic-Peles, A., Pivac, N., Jakovljevic, M., Muck-Seler, D. (2009). Lipid levels in female patients with affective disorders. Psychiatry Research,168(3): 218-21. doi: 10.1016/j.psychres.2008.06.048.

Dias, Ana Claudia Vesper Manier, (2016) "Diagnostic Practices of Autism Spectrum Disorders in Brazil" Honors Theses. 149.

https://digitalcommons.andrews.edu/cgi/viewcontent.cgi?article=1148&context=honors

Xu, F., Lu, X., Cheng, R., Zhu, Y., Miao, S., Huang, Q., Xu, Y., Qiu, L., Zhou, Y. (2020). The influence of exposure to Toxoplasma Gondii on host lipid metabolism. BMC Infectious Diseases, 20(1):415. doi.org/10.1186/s12879-020-05138-9

Siahanidou, T., Mandyla, H., Papassotiriou, G. P., Papassotiriou, I., Chrousos, G. (2007). Circulating levels of adiponectin in preterm infants.Archives of Disease in Childhood. Fetal and Neonatal Edition, 92(4): 286–290. doi: 10.1136/adc.2006.106112

Lenz, A. M., Diamond, F. (2012). The importance of the adiponectin and leptin relationship in in-utero and infant growth. Handbook of Growth and Growth Monitoring in Health and Disease, 2839-2856.

Quan, L., Zhao, Y., Yi, J., Shi, X. D., Zhong, Y., Li (2021). Serum adiponectin levels are reduced in autism spectrum disorder and are associated with severity of symptoms. Metabolic Brain Disease, 36(3): 491–8. doi: 10.1186/s12888-024-05529-1

Zuheir, H. A., Al-Kafaji, G., Al-Sherawi, M. I., Razzak, R. A., Eltayeb, D. (2019). Investigation of Serum Levels of Leptin, Ghrelin and Growth Hormone in Bahraini Children with Autism. International Archives of Translational Medicine, 5(1): 2572-4142. DOI: 10.23937/2572-4142.1510007

Ashwood, P., Kwong, C., Hansen, R., Hertz-Picciotto, I., Croen, L. et al. (2008). Brief report: Plasma leptin levels are elevated in autism: Association with early onset phenotype? Autism and Developmental Disorders, 38(1): 169-175. doi: 10.1007/s10803-006-0353-1.

Al-Zaid, F. S., Alhader, A. A., Al-Ayadhi, L. Y. (2014) Altered ghrelin levels in boys with autism: A novel finding associated with hormonal dysregulation. Scientific Reports, 4(1): 6478. doi: 10.1038/srep06478

Klok, M. D., Jakobsdottir, S., Drent, M. L. (2007) The role of leptin and ghrelin in the regulation of food intake and body weight in humans: A review. Obesity Reviews, 8(1):21-34. doi: 10.1111/j.1467- 789X.2006.00270.x.

Fantuzzi, G., Faggioni, R. (2008) Leptin in the regulation of immunity, inflammation, and hematopoiesis. Leukocyte Biology, 68(4): 437-446. https://pubmed.ncbi.nlm.nih.gov/11037963/

Milovanović, I., Vujanić, M., Klun, I., Bobić, B., Nikolić, A., Ivović, V., Trbovich, A. M., Djurković- Djaković, O. (2009). Toxoplasma gondii infection induces lipid metabolism alterations in the murine host.Memórias do Instituto Oswaldo Cruz, 104(2) : 175-8. DOI: 10.1590/s0074-02762009000200008

Chieh, A. Y., Bryant, B. M., Kim, J. W., Li, L. (2021). Systematic review investigating the relationship between autism spectrum disorder and metabolic dysfunction. Research in Autism Spectrum Disorders, 86:101821. doi: 10.1016/j.rasd.2021.101821

Published

2024-09-23

How to Cite

Fityan, K. T., & Al-Warid, H. S. (2024). Toxoplasmosis and Metabolic Disorders among Children with Autism. Nigerian Journal of Parasitology, 45(2), 434–449. https://doi.org/10.4314/njpar.v45i2.19

Issue

Section

Main Issues

Similar Articles

1 2 3 4 5 6 > >> 

You may also start an advanced similarity search for this article.